Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.06
30% from low
Exchange
OTC Link
OS
Borrow rate
1.46%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $2.8M | $107.5K | $881.2K | $1.5M | $6.5M | $23.2M | $4.2M |
| Cost of revenue | $253 | $225 | $360.0K | $793.1K | $1.6M | $4.7M | $14.8M | $3.0M |
| Gross profit | −$253 | $2.8M | −$252.5K | $88.0K | −$81.5K | $1.8M | $8.4M | $1.2M |
| Gross margin | — | 100.0% | -234.9% | 10.0% | -5.4% | 27.4% | 36.1% | 28.0% |
| R&D | $0 | $113.3K | $148.2K | $188.5K | $1.4M | $1.9M | $1.2M | $26.4K |
| Operating income | −$248.2K | −$251.6K | −$6.4M | −$7.3M | −$15.4M | −$27.5M | −$27.0M | −$11.7M |
| EBITDA | −$247.9K | −$2.4M | −$7.2M | −$6.8M | −$15.1M | −$27.9M | −$26.7M | −$13.9M |
| Net income | −$259.6K | −$279.1K | −$7.2M | −$9.6M | −$18.9M | −$44.9M | −$30.3M | −$19.6M |
| Net margin | — | -9.9% | -6736.0% | -1089.5% | -1245.6% | -691.1% | -130.5% | -471.2% |
| EPS (diluted) | -0.12 | -0.13 | -2.51 | -0.15 | -0.11 | -0.21 | -0.11 | -0.05 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $35M | $0.01 | $0.01–$0.01 | 1 |
| 2027 | $51M | $0.01 | $0.01–$0.01 | 1 |
| 2028 | $66M | $0.03 | $0.03–$0.03 | 1 |
Forward consensus · source: Financial Modeling Prep
NUMINUS WELLNESS INC
No one on the platform currently holds NUMIF.
No tracked institution reports a position in NUMIF as of their last filing.
No one on the platform has traded NUMIF yet.
| $10M |
| — |
| IMUCEOM Pharmaceuticals Holdings, Inc. | $0.27 | +22.68% | $34M | — |
| LUFFFHerbal Dispatch Inc. | $0.03 | +2.07% | $10M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.3× sales vs its 6.7× historical median P/S.
Fair value ≈ $0.43 · price $0.02 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$NUMIF when will this scam company be relisted again so that I can sell it..stupid scam, can't believe I have share in this.
View on StockTwits ↗$NUMIF it’s actually so annoying that Canadians can’t buy this still. I really hope we don’t actually have to wait until August 31 for the relisting ☹️
View on StockTwits ↗$NUMIF will this sh!te move when psilocybin is approved? $CMPS
View on StockTwits ↗$NUMIF looking like a potential candidate here. Looking into the best Ketamine therapy/research ticker. Maybe I am late to the trade?
View on StockTwits ↗$NUMIF having a heart attack seeing this current price (0.018) while looking at my stock account and seeing otherwise (0.035). Ffs 🤦♂️
View on StockTwits ↗$NUMIF I’m a bag holder with 24k shares. Averaged down to $.08 a while back so nothing left to do but wait and see if it ever springs back.
View on StockTwits ↗$NUMIF they get delisted tomorrow 4/22 and won’t trade anywhere, not even pink slips until they get properly audited and then have to get approved for a re-listing. Another thing to note: their US facilities got bought out, so they only have treatment centers in Canada. I got out today at .04 and would advise you do the same if you’re still in this name.
View on StockTwits ↗$RVVTF Anyone here who got burned by $NUMIF and their saga?
View on StockTwits ↗$NUMIF bruh it’s deleted on tsx. Would of been nice to have some gains today
View on StockTwits ↗$NUMIF Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies https://marketwirenews.com/stock/numif/news/numinus-wellness-responds-to-trump-executive-order-o-7752815103427251.html?utm_source=stocktwits
View on StockTwits ↗https://nfne.ws/293317 $NUMIF $NUMI.TSX @numinushealth #mentalhealth #psychedelic #OTC #OTCMarkets #OTCStocks #TSX #Investing
View on StockTwits ↗$NUMIF every single long term stock I hold is absolute trash, I need to stick to what I’m good at
View on StockTwits ↗$NUMIF not to be blindly optimistic, but this crash might the best thing to happen to us small buyers. Nothing has changed to their goals. They’re still partnered with Stella in providing service through clinics, they still have CCR for research, they still plan to be the backbone to educating future psychedelic practitioners. Now it’s just dirt cheap to buy before moving over to CSE, which is less stringent than TSX and has way more fintech and started biotech freedoms. (P.S. $DRUG is also on CSE and is doing just fine 👍🤞🙏)
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.